看多
RARX Here I am and ready to party
已更新
Ra Pharmaceuticals to Present at the RBC Capital Markets 2018 Global Healthcare Conference
Ra Pharmaceuticals, Inc. (RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018 at 8:00 a.m. E.T. The conference is being held at the Lotte New York Palace Hotel.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks,source: yahoo.com
Insider RA CAPITAL MANAGEMENT, LLC reports buying 2,500,000 shares of RRARX at $6.00 for a total cost of $15,000,000.00 fintel.io/n/us/rarx
Ra Pharmaceuticals, Inc. (RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the RBC Capital Markets 2018 Global Healthcare Conference on Wednesday, February 21, 2018 at 8:00 a.m. E.T. The conference is being held at the Lotte New York Palace Hotel.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks,source: yahoo.com
Insider RA CAPITAL MANAGEMENT, LLC reports buying 2,500,000 shares of RRARX at $6.00 for a total cost of $15,000,000.00 fintel.io/n/us/rarx
註釋
Price moved as expected :)
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。